首页 | 本学科首页   官方微博 | 高级检索  
检索        

短暂性脑缺血发作进展为脑梗死的早期危险分层和干预的临床研究
引用本文:曾宪杰,孙光裕,陈玉芳,黄铿伟,陈幼璇.短暂性脑缺血发作进展为脑梗死的早期危险分层和干预的临床研究[J].河北医学,2014,20(2):204-206.
作者姓名:曾宪杰  孙光裕  陈玉芳  黄铿伟  陈幼璇
作者单位:曾宪杰 (广东省潮州市潮州医院神经内科,广东 潮州,521000); 孙光裕 (广东省潮州市潮州医院神经内科,广东 潮州,521000); 陈玉芳 (广东省潮州市潮州医院神经内科,广东 潮州,521000); 黄铿伟 (广东省潮州市潮州医院神经内科,广东 潮州,521000); 陈幼璇 (广东省潮州市潮州医院神经内科,广东 潮州,521000);
摘    要:目的:对短暂性脑缺血发作(TIA)病例进行风险性分层,并对特定危险组给予积极临床干预,评价其在降低脑梗死发生率中的价值。方法:160例TIA住院患者,随机分为研究组和对照组各80例。研究组使用改良的ABCD2评分方法进行低危、中危、高危分组,中危以上病例在常规治疗基础上,加用低分子肝素钙和奥扎格雷钠两种药物治疗,记录发病7d内的脑梗死发生率;对照组不进行危险分层,使用常规治疗,记录7d内脑梗死发生率。结果:研究组脑梗死发生率为5%(4例),对照组脑梗死发生率为16.25%(13例)。两组脑梗死发生率比较,研究组低于对照组,有显著性差异(p〈0.05),治疗过程无严重的或导致治疗中止的不良反应。结论:本方法对降低TIA进展为脑梗死发生率、改善TIA预后具有临床价值。

关 键 词:短暂性脑缺血发作  脑梗死  ABCD2评分  低分子肝素钙  奥扎格雷钠

The Research of Early risk Stratification and Intervention of TIA Progressing into Cerebral Infarction
Institution:ZENG Xianjie;SUN Guangyu;CHEN Yufang;Chaozhou Hospital of Chaozhou;
Abstract:Objective: Transient ischemic attack patients were divided into low,medium and high risk group,and the specific risk group gave a positive clinical intervention.To evaluate its value to reduce the incidence of cerebral infarction. Method: 160 patients were from clinic or hospital at chaozhou hospital. They were randomly divided into two groups: research group and control group( n = 80) 。The research group redivided into low,medium and high risk group by improve ABCD2 grade,medium and high risk group add FraxiParine and ozagrel sodium on the basis of normal treatment,the control group were given normal treatment,recorded incidence rates of cerebral infarction in the two groups. Result: The incidence rate of the research group was 5%,and the rate of control group was 16.25%. Two groups incidence rate comparison,the research group was lower than that of control group. There is significantly statistical difference( P < 0. 05).Conculsion: The technique has great value of preventing transient ischemic attack progressing into Cerebral infarction.
Keywords:Transient ischemic attack  Cerebral infarction  ABCD2 grade  FraxiParine  Ozagrel sodium
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号